Emilie Sbidian

EPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), EpiDermE Epidemiology in Dermatology and Evaluation of Therapeutics, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Est Créteil University, Créteil, France, France

Disclosure information not submitted.

Presentation(s):

• Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System

  Monday, August 26, 2024
  5:50 PM – 5:55 PM CEST